Strathspey Crown

Strathspey Crown

Strathspey Crown operates as a growth equity holding company under Chairman and Managing Partner Robert Edward Grant. Grant established the Newport Beach firm after senior operating roles at Allergan Medical and Bausch & Lomb Surgical, bringing a surgeon-lens to dealmaking. The firm describes its founding partnership as physician investors across plastic surgery, ophthalmology, dermatology, cardiology, and orthopedics — a clinical anchor that shapes much of the portfolio. The strategy spans healthcare, financial technology, clean energy, and social media, with an emphasis on complexity and high barriers to entry. Healthcare commitments include Alphaeon Corporation, a lifestyle healthcare platform that took Evolus (NASDAQ: EOLS) public for aesthetic neurotoxins, and Revance Therapeutics collaborator Zelegent, which targets snoring reduction. Outside healthcare, the firm backs Bluon, an HVAC technician platform aggregating data on more than 138,800 equipment models, and Crown Sterling, a fintech subsidiary developing quantum-secure NFT encryption for personal data sovereignty. Geographically, activity concentrates in the United States, with select international reach. Team scale is not publicly disclosed. In April 2017, Grant also launched physician-access service Concierge Key Health, which he led as founding CEO until July 2018. He chairs the Young President's Organization Southern California chapter and sits on boards at Chapman University's Schmid College and UC Irvine's engineering and law schools. The entity does not publish deployment figures. Architecturally, Strathspey Crown differs from a traditional private equity fund: it is structured as a holding company with operating subsidiaries rather than a closed-end commingled vehicle. That permanent-capital posture allows Grant to hold positions indefinitely, blending incubation, venture, and control equity across sectors he personally understands.